BRUGNOLI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 4.320
AS - Asia 2.290
EU - Europa 1.631
SA - Sud America 459
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.745
Nazione #
US - Stati Uniti d'America 4.229
SG - Singapore 941
CN - Cina 629
IT - Italia 543
BR - Brasile 389
PL - Polonia 266
DE - Germania 216
VN - Vietnam 213
HK - Hong Kong 200
UA - Ucraina 151
GB - Regno Unito 137
TR - Turchia 99
FI - Finlandia 78
ID - Indonesia 68
RU - Federazione Russa 56
CA - Canada 50
SE - Svezia 43
MX - Messico 36
IN - India 33
FR - Francia 30
NL - Olanda 29
AR - Argentina 27
ZA - Sudafrica 26
BD - Bangladesh 21
ES - Italia 20
JP - Giappone 20
AT - Austria 17
LT - Lituania 15
BE - Belgio 14
EC - Ecuador 13
IQ - Iraq 11
CO - Colombia 9
MA - Marocco 9
KR - Corea 7
PK - Pakistan 7
PY - Paraguay 7
IR - Iran 6
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
CL - Cile 4
CZ - Repubblica Ceca 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
KE - Kenya 3
UY - Uruguay 3
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
GY - Guiana 2
IL - Israele 2
PH - Filippine 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.745
Città #
Singapore 527
Ashburn 486
Fairfield 391
Woodbridge 359
Ferrara 300
Warsaw 264
Beijing 243
Santa Clara 227
Houston 216
Ann Arbor 206
Chandler 206
Hong Kong 200
Seattle 162
Jacksonville 152
Dallas 150
Cambridge 148
Wilmington 131
Los Angeles 104
New York 101
Izmir 66
Ho Chi Minh City 65
Munich 65
Princeton 57
Jakarta 55
Nanjing 52
Hanoi 41
Shanghai 39
São Paulo 38
Buffalo 37
San Diego 33
The Dalles 32
Addison 25
Turku 25
Boardman 24
Bologna 22
Chicago 21
Johannesburg 21
Manchester 21
London 20
Helsinki 19
Nanchang 19
Montreal 18
Orem 18
Brooklyn 17
Hefei 17
Milan 17
Nuremberg 17
Toronto 17
Atlanta 16
Bremen 15
Denver 15
Stockholm 15
Auburn Hills 14
Chennai 14
Shenyang 14
Tokyo 14
Brussels 13
Mexico City 13
Poplar 13
Tianjin 13
Dearborn 12
Dong Ket 12
Falkenstein 12
Rimini 12
Boston 11
Council Bluffs 11
Falls Church 11
San Francisco 11
Moscow 10
Rio de Janeiro 10
Campinas 9
Changsha 9
Phoenix 9
Vienna 9
Belo Horizonte 8
Da Nang 8
Jinan 8
Mountain View 8
Norwalk 8
Ankara 7
Augusta 7
Biên Hòa 7
Catania 7
Dhaka 7
Frankfurt am Main 7
Goiânia 7
Haiphong 7
Ariano nel Polesine 6
Baghdad 6
Düsseldorf 6
Guangzhou 6
Hải Dương 6
Leawood 6
Querétaro 6
Salt Lake City 6
Tampa 6
Asunción 5
Brasília 5
Buenos Aires 5
Caxias do Sul 5
Totale 5.978
Nome #
A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report 247
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells 221
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 213
Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells 204
In triple negative breast tumor cells, PLC-beta 2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness 200
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 197
CD133 in Breast Cancer Cells: More than a Stem Cell Marker 196
Up-modulation of PLC-beta2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: A promising target for preventing progression of TNBC 186
Mitigation of tumor necrosis factor alpha cytotoxicity by aurintricarboxylic acid in human peripheral B lymphocytes 183
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process 182
VAV PROMOTES DIFFERENTIATION OF HUMAN TUMORAL MYELOID PRECURSORS 182
Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells 178
Mass spectrometry-based identification of Y745 of Vav1 as a tyrosine residue crucial in maturation of acute promyelocytic leukemia-derived cells 173
Vav1 downmodulates Akt in different breast cancer subtypes: A new promising chance to improve breast cancer outcome 170
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells 166
Retinoic acid maintains differentiated cell morphology and functions in long-term cultured porcine hepatocytes: Obtaining functional cells for prolonged treatments with bioartificial liver 161
Ornithine decarboxylase, polyamines and CD11b expression in HL-60 cells during differentiation induced by retinoic acid 161
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays 158
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 157
hnRNP K in PU.1-containing complexes recruited at theCD11bpromoter: a distinct role in modulating granulocytic and monocytic differentiation of AML-derived cells 157
Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: Role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation 156
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 155
Vav1 modulates protein expression during ATRA-lnduced maturation of APL-derived promyelocytes: A proteomic-based analysis 154
Vav1 is a crucial molecule in monocytic/macrophagic differentiation of myeloid leukemia-derived cells 153
Nuclear proteome analysis reveals a role of Vav1 in modulating RNA processing during maturation of tumoral promyelocytes 149
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 145
Ethanol-based garlic extract prevents malignant evolution of non-invasive breast tumor cells induced by moderate hypoxia 145
Vav1 in differentiation of tumoral promyelocytes 141
The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells 139
UC.183, UC.110, and UC.84 ultra-conserved RNAs are mutually exclusive with mir-221 and are engaged in the cell cycle circuitry in breast cancer cell lines 136
PLCB2 (phospholipase C, beta 2). 134
null 134
Vav1: a key player in aginist-induced differentiation of promyelocytes from Acute Myeloid leukemia (APL). 126
Nuclear inositide-metabolism in granulocytic differentiation of myeloid cells. 125
RNA interference in the study of molecular mechanisms activated during agonist induced differentiation of acute promyelocytic leukemia derived promyelocytes 123
Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells 121
Pulsed Electromagnetic Fields Modulate miRNAs During Osteogenic Differentiation of Bone Mesenchymal Stem Cells: a Possible Role in the Osteogenic-angiogenic Coupling 121
PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors 120
Effects of garlic extract on breast tumor cells: a phenotype dependent modulation of morphology, cell cycle and invasive potential 118
Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells 118
Imidazo[1,2-b]pyrazole-7-carboxamide derivative induces differentiation-coupled apoptosis of immature myeloid cells such as acute myeloid leukemia and myeloid-derived suppressor cells 114
Chlorogenic acid permeation across intestinal cell monolayers: influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 112
Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 103
The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO 102
Inositide-modifying enzymes: a cooperative role in regulating nuclear morphology during differentiation of myeloid cells. 100
EVALUATION OF DIFFERENT STORAGE CONDITIONS ON CHEMICAL COMPOSITION AND BIOACTIVE COMPOUNDS OF VOGHIERA GARLIC PDO 95
The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma 94
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines 93
Phosphoinositide 3-kinase is associated to the nucleus of HL-60 cells and is involved in their ATRA-induced granulocytic differentiation 93
In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness 92
Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation of Akt Signaling 90
Deregulated microRNAs in breast ductal carcinoma in situ (DCIS) with invasive propensity 88
Insights into the development of insulin-producing cells: Precursors correlated involvement of microRNA panels 87
Targeting the Vav1/miR‐29b axis as a potential approach for treating selected molecular subtypes of triple‐negative breast cancer 87
Selective up-regulation of phospholipase C-beta 2 during granulocytic differentiation of normal and leukemic hematopoietic progenitors 81
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 76
Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype 71
ROLE OF VAV1 IN DIFFERENTIATION ALONG THE MONOCYTIC-MACROPHAGIC LINEAGE OF TUMORAL MYELOID PRECURSORS 69
Vav1 regulates phenotypic differentiation of AML-derived promyelocytes to monocytes/macrophages 68
Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA) 65
The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2 65
Modulation of Vav1 in differentiation of hiPSCs to β cells: a potential strategy to enhance outcomes of in vitro-generated insulin producing cells transplantation 60
THE MULTIDOMAIN PROTEIN VAV1 IN THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO INSULIN-PRODUCING CELLS 60
Metabolic fingerprinting of breast cancer cell lines: discovering similarities and differences 59
PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential 59
Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches 58
PLC-beta2 activity on actin-associated polyphosphoinositides promotes migration of differentiating tumoral myeloid precursors. 58
Novel Insights into the Mechanism of Action and Modulation of Microvesicle Release by Nitroxoline in Pancreatic Cancer Cells Using Integrative Proteomic and Functional Analyses 57
Effects of garlic on Breast Tumor cells: a selective modulation of growth, invasive potential and Akt signaling 53
Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype 50
null 45
Phenotype-dependent role of Vav1 in down-modulating Akt in invasive breast tumor cells 37
Dual Role of Diallyl Disulfide (DADS) on Invasive Potential and β-Catenin Dynamics in HER2-Positive Breast Cancer Cells 24
Inhibition of cancerous properties of triple-negative MDA-MB-436 cells by targeting the K+ voltage-dependent Kv2.1 channel 21
MicroRNA 375 and diabetes: A key regulator of β cell function and a promising non-invasive biomarker 16
Vav1 Sustains the Expression of Insulin, PDX1 and miR-375 During Differentiation of hiPSCs to β Cells: A Potential Target to Improve the In Vitro Generation of Insulin-Producing Cells 3
Totale 8.910
Categoria #
all - tutte 44.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.075
Totale 45.531


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021502 0 0 0 0 0 88 71 94 26 107 65 51
2021/2022523 16 46 49 29 15 44 29 34 12 54 46 149
2022/2023536 52 33 29 59 74 54 26 73 62 2 42 30
2023/2024384 31 37 5 13 21 79 17 48 11 9 17 96
2024/20251.702 46 50 146 77 201 157 73 109 201 218 253 171
2025/20262.883 517 253 475 610 743 285 0 0 0 0 0 0
Totale 8.910